Hennion & Walsh Asset Management, Inc.
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1861642
Parsippany, NJ
Position in KALV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$7,568,779
+$2,048,403 QoQ
Shares Held
375,995
+10.0% QoQ
Ownership
0.706%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#35
of 182 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Hennion & Walsh Asset Management, Inc. holds $181,506,492 across 60 Biotechnology names. KALV ranks #6 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CELC |
Celcuity Inc.
|
182,601 | $20,842,078 | |
| 2 | COGT |
Cogent Biosciences, Inc.
|
326,472 | $12,565,907 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
49,352 | $9,329,995 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
93,592 | $8,646,028 | |
| 5 | DAWN |
Day One Biopharmaceuticals, Inc.
|
367,134 | $7,871,352 | |
| 6 | KALV |
KalVista Pharmaceuticals, Inc.
This page
|
375,995 | $7,568,779 | |
| 7 | OLMA |
Olema Pharmaceuticals, Inc.
|
481,485 | $7,178,941 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
36,633 | $6,191,709 |
All Filings in KALV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,568,779 | 375,995 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $5,520,376 | 341,819 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,150,780 | 176,583 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,763,139 | 155,961 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,282,163 | 111,106 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $633,784 | 74,827 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||